🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

UBS Navigates Complex Regulatory Terrain in Bid for Full Control of China Platform

Published 09/04/2024, 19:20
Updated 09/04/2024, 20:40
© Reuters.  UBS Navigates Complex Regulatory Terrain in Bid for Full Control of China Platform
UBSG
-

Benzinga - by Vandana Singh, Benzinga Editor.

UBS Group AG (NYSE:UBS) is reportedly in discussions to attain full ownership of its China platform through a strategic swap involving its stake in Credit Suisse’s onshore securities venture.

The Zurich-based lender is reportedly eyeing the 33% stake held by Beijing State-Owned Assets Management Co. in their joint venture UBS Securities Co., in exchange for selling part or all of its 51% stake in Credit Suisse Securities (China) to a Beijing government investment fund.

This development adds a new dimension to the ongoing bidding war for Credit Suisse’s investment bank in China. Notable players such as Ant Group Co., backed by Chinese billionaire Jack Ma, and Citadel Securities LLC, led by Ken Griffin, are actively participating.

Selling the Credit Suisse venture to the Beijing government could deter formidable contenders like Citadel, renowned for its expertise in market-making and trading execution.

Chinese regulations prohibit a foreign shareholder from concurrently holding majority stakes in two domestic brokerages, the Bloomberg report added.

UBS has been seeking to increase its ownership to 100%, but the Beijing government has hesitated, considering the onshore business’s promising growth and earnings prospects.

UBS is pursuing a dual-track process, negotiating with its state-owned shareholder for share swaps and engaging in advanced discussions to sell Credit Suisse Securities to Citadel Securities.

However, both potential deals face regulatory challenges, primarily concerning the Chinese government’s preference regarding ownership of foreign-owned brokerages.

UBS has been aiming to sell the entire Credit Suisse China unit for approximately 2 billion yuan, which includes the stake owned by its local partner.

Citadel Securities made a bid in late December ranging from 1.5 billion yuan to 2 billion yuan, lower than a competing offer from Ant Group.

Credit Suisse previously agreed to purchase the remaining 49% stake from its Chinese partner for 1.14 billion yuan, valuing the firm at around 2.3 billion yuan, but this deal fell through after UBS took over.

Price Action: UBS shares are down 1.27% at $30.76 on the last check Tuesday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo via Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.